Catalys Pacific, LLC — Q4 2024 13F-HR

← Catalys Pacific, LLC

Q4 2024 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2025-02-14 · accession 0001104659-25-013740

$115.9M

Reported value

Positions

2024-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
603170101	MLYS	Mineralys Therapeutics, Inc.	$106.4M	91.8%	8,644,579	Common	SOLE
71722W107	PHAT	Phathom Pharmaceuticals, Inc.	$9.5M	8.18%	1,167,114	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.